Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy

Cell

Volumn 98, Issue 4, 1999, Pages 465-474

  Coral Vazquez, Ramon ^a   Cohn, Ronald D ^a   Moore, Steven A ^a   Hill, Joseph A ^a,b   Weiss, Robert M ^a,b   Davisson, Robin L ^a   Straub, Volker ^a   Barresi, Rita ^a   Bansal, Dimple ^a   Hrstka, Ron F ^a   Williamson, Roger ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SARCOGLYCAN;

ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; GENE MUTATION; GENETIC ENGINEERING; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0033588050     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81975-3     Document Type: Article

References (25)

1. Arber, S., Hunter, J.J., Ross, J., Jr., Hongo, M., Sansig, G., Borg, J., Perriard, J.C., Chien, K.R., and Caroni, P. (1997). MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403.
2. Badorff, C., Lee G.H., Lamphear, B.J., Maitone, M.E., Campbell, K.P., Rhoads, R.E., and Knowlton, K.U. (1999). Enteroviral protease 2 Àcleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5, 320-326.
3. Bonne, G., Di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, E.H., Merlini, l., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, U.A., et al. (1999). Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21, 285-288.
4. Crosbie, R.H., Heighway, J., Venzke, D.P., Lee, U.C., and Campbell, K.P. (1997). Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J. Biol. Chem. 272, 31221-31224.
5. Crosbie, R.H., Lebakken, O.S., Holt, K.H., Venzke, O.P., Sträub, V., Lee, U.C., Grady, R.M., Chamberlain, U.S., Sanes, U.R., and Campbell, K.P (1999). Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J. Cell Biol. 145, 153-165.
6. Duclos, F., Straub, V., Moore, S.A., Venzke, D.P., Hrstka, R.F., Crosbie, R.H., Durbeej, M., Lebakken, C.S., Ettinger A.J., and van der Meulen, J., et al. (1998). Progressive muscular dystrophy in alphasarcoglycan-deficient mice. J. Cell Biol. 742, 1461-1471.
7. Ervasti, J.M., and Campbell, K.P. (1993). A role for the dystrophinglycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823.
8. Factor, S.M., Minase, T., Cho, S., Dominitz, R., and Sonnenblick, E.H. (1982). Microvascularspasm in the cardiomyopathic hamster: a preventable cause of focal myocardial necrosis. Circulation 66, 342-354.
9. Fewell, J.G., Osinska, H., Klevitsky, R., Willie, N.G., Sfyris, G., Bahrehmand, F., and Robbins, J. (1997). A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. Am. J. Physiol. 273, H1595-H1605.
10. Hack, A.A., Ly, C.T., Jiang, F., Clendenin, C.J., Sigrist, K.S., Wollmann, R.L., and McNally, E.M. (1998). Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol. 142, 1279-1287.
11. Kaski, U.C. (1995). Management of vasospastic angina-role of Nicorandil. Cardiovasc. Drugs Ther. 9, 221-227.
12. Kukovetz, W.R., Holzmann, S., and Poech, G. (1992). Molecular mechanism of action of Nicorandil. J. Cardiovasc. Pharmacol. 20, S1-S7.
13. Lim, L.E., and Campbell, K.P. (1998). The sarcoglycan complex in limb-girdle muscular dystrophy. Curr. Opin. Neurol. 11, 443-452.
14. Melacini, P., Fanin, M., Duggan, D.J., Freda, M.P., Berardinelli, A., Danieli, G.A., Barchitta, A., Hoffman, E.P., Dalla Volta, S., and Angelini, C. (1999). Heart involvement in muscular dystrophy due to sarcoglycan gene mutations. Muscle Nerve 22, 473-479.
15. Milner, D.J., Weitzer, G., Tran, D., Bradley, A., and Capetanaki, Y. (1996). Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J. Cell Biol. 134, 1255-1270.
16. Moreira, E.S., Vainzof, M., Marie, S.K., Nigro, V., Zatz, M., and Passos-Bueno, M.R. (1998). A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGM D2F) in Brazilian sarcoglycanopathies. J. Med. Genet. 35, 951-953.
17. Nigro, V., de Sa Moreira, E., Piluso, G., Vainzof, M., Belsito, A., Politano, L., Puca, A.A., Passos-Bueno, M.R., and Zatz, M. (1996). Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14, 195-198.
18. Noguchi, S., McNally, E.M., Ben Othmane, K., Hagiwara, Y., Mizuno, Y., Yoshida, M., Yamamoto, H., Bonnemann, C.G., Gussoni, E., Denton, P.H., et al. (1995). Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270, 819-822.
19. Olson, T.M., Michels, V.V., Thibodeau, S.N., Tai, Y.S., and Keating, M.T. (1998). Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280, 750-752.
20. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
21. Roberds, S.L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R.D., Lim, L.E., Lee, J.C., Tome, F.M., Romero, N.B., et al. (1994). Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78, 625-633.
22. Sakamoto, A., Abe, M., and Masaki, T. (1999). Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett. 447, 124-128.
23. Straub, V., and Campbell, K.P. (1997). M uscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168-175.
24. Straub V., Ettinger, A.J., Durbeej, M., Venzke, D.P., Cutshall, S., Sanes, J., and Campbell, K.P. (1999). ∈-saicoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J. Biol. Chem., in press.
25. Towbin, J.A. (1998). The role of cytoskeletal proteins in cardiomyopathies. Curr. Opin. Cell Biol. 10, 131-139.